fbpx
March 27, 2020

EMA Panel Backs Zolgensma Gene Therapy for SMA EMA Panel Backs Zolgensma Gene Therapy for SMA

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting conditional marketing authorization for onasemnogene abeparvovec (Zolgensma, AveXis […]
March 27, 2020

CHMP Backs Ozanimod (Zeposia) for Multiple Sclerosis CHMP Backs Ozanimod (Zeposia) for Multiple Sclerosis

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of ozanimod (Zeposia, Celgene Europe BV) for adults […]
March 27, 2020

EMA Review of DOACs Concludes Risk-Benefit Remains Positive EMA Review of DOACs Concludes Risk-Benefit Remains Positive

There is no need to change the conditions for use of the direct oral anticoagulants (DOACs) apixaban (Eliquis), dabigatran etexilate (Pradaxa), and rivaroxaban (Xarelto) in Europe, […]
March 27, 2020

EMA Says Stay on Angiotensin Drugs During COVID-19 Pandemic EMA Says Stay on Angiotensin Drugs During COVID-19 Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The European Medicines Agency (EMA) has issued a statement advising that patients […]
March 26, 2020

FDA Clears Ozanimod (Zeposia) for MS; COVID-19 Delays Launch FDA Clears Ozanimod (Zeposia) for MS; COVID-19 Delays Launch

The US Food and Drug Administration (FDA) has approved ozanimod (Zeposia, Bristol Myers Squibb) for adults with relapsing forms of multiple sclerosis (RMS), although the company […]
March 25, 2020

EpiPens May Malfunction, Delaying Life-Saving Med, FDA Warns EpiPens May Malfunction, Delaying Life-Saving Med, FDA Warns

Epinephrine auto-injectors (EpiPen 0.3 mg, EpiPen Jr 0.15 mg, and generics), used to treat severe allergic reactions, could potentially have delayed injections or fail to inject […]
March 20, 2020

Match Day Sets New Record, Celebrations Muted by COVID-19 Match Day Sets New Record, Celebrations Muted by COVID-19

The 2020 Main Residency Match celebrated its largest in history. A record 40,084 US and international applicants submitted program choices for 37,256 available positions, an increase […]
March 19, 2020

20% of US COVID-19 Deaths Were Young Adults 20% of US COVID-19 Deaths Were Young Adults

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. FROM MMWR A review of more than 4,000 U.S. patients who were […]
March 16, 2020

Coronavirus: American Psychiatric Association Cancels Meeting Coronavirus: American Psychiatric Association Cancels Meeting

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In the wake of travel restrictions and public health guidance regarding the […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0